Analyze DCF forecasts for the company and compare them with competitors.
631.73B
Revenue has increased from the previous period.
10.07%
Revenue growth rate is unchanged from the previous period.
207.46B
EBITDA has increased from the previous period.
32.84%
EBITDA margin is unchanged from the previous period.
187.42B
EBIT has increased from the previous period.
29.67%
EBIT margin is unchanged from the previous period.
20.04B
Depreciation has increased from the previous period.
120.32B
Total cash has increased from the previous period.
19.05%
Cash percentage is unchanged from the previous period.
96.05B
Receivables have increased from the previous period.
15.20%
Receivables percentage is unchanged from the previous period.
10.17B
Inventories have increased from the previous period.
1.61%
Inventory percentage is unchanged from the previous period.
101.85B
Accounts payable has increased from the previous period.
16.12%
Payables percentage is unchanged from the previous period.
-17.29B
Capital expenditure has increased from the previous period.
-2.74%
CapEx percentage is unchanged from the previous period.
8.77%
WACC is unchanged from the previous period.
8.94%
Cost of equity is unchanged from the previous period.
3.71%
Cost of debt is unchanged from the previous period.
1.11
Beta is unchanged from the previous period.
15.41B
Diluted shares outstanding is unchanged from the previous period.
119.06B
Total debt is unchanged from the previous period.
3.95T
Total equity is unchanged from the previous period.
4.06T
Total capital is unchanged from the previous period.
2.93%
Debt weighting is unchanged from the previous period.
97.07%
Equity weighting is unchanged from the previous period.
156.41B
EBIAT has increased from the previous period.
158.76B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
3.46T
Terminal value is unchanged from the previous period.
2.78T
Enterprise value is unchanged from the previous period.
89.12B
Net debt is unchanged from the previous period.
2.69T
Equity value is unchanged from the previous period.
174.81
Equity value per share is unchanged from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
41.28B
The estimated revenue has increased from the previous period.
9.85B
The estimated EBITDA has increased from the previous period.
0.18
The estimated EPS has increased from the previous period.
6.57B
The estimated net income has increased from the previous period.
9.04B
The estimated EBIT has increased from the previous period.
3.71B
The estimated SG&A expenses have increased from the previous period.